Position in ALNY
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$609,462
-$90,004 QoQ
Shares Held
1,842
+4.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DAVENPORT & Co LLC holds $119,148,472 across 17 Biotechnology names. ALNY ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,152 | $93,841,274 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
238,238 | $17,889,291 | |
| 3 | CGTX |
Cognition Therapeutics Inc
|
2,892,808 | $2,198,534 | |
| 4 | GMAB |
Genmab A/S
|
44,901 | $1,204,693 | |
| 5 | ARGX |
Argenx SE
|
935 | $682,783 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,842 | $609,462 | |
| 7 | MGTX |
MeiraGTx Holdings plc
|
69,200 | $599,272 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
488 | $377,048 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $609,462 | 1,842 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $699,466 | 1,759 | Shares | Sole | 2026-01-12 | |
| 2021-12-31 | $628,293 | 3,705 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $645,163 | 3,417 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $488,895 | 2,884 | Shares | Sole | 2021-07-28 | |
| No filing history on record for this holder in this stock. | ||||||